A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said: “Our results show that, by using NeuroSAFE, nearly twice as many men don’t have to ...
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...